Page results
-
Information for patients having chemotherapy for ovarian, tubal or primary peritoneal cancer, or who have been newly diagnosed with pancreatic cancer or cholangiocarcinoma.
-
The department undertakes specialist dental treatment for those under 16 years of age ( 15 years and 11 months), and deals with the aetiology, prevention, diagnosis and treatment of oral disorders; mouth conditions and teeth of children.
-
This page has been written by the Neuropsychiatry Department at the National Hospital for Neurology and Neurosurgery. The aim of this page is to provide general information about the procedure called Repetitive Transcranial Magnetic Stimulation (rTMS).
-
This information has been written for patients who have been referred for High Dose Rate (HDR) brachytherapy to the oesophagus (gullet).
-
This page has been written for patients who have been referred for High Dose Rate (HDR) brachytherapy to the bronchus
-
UCLH is the first NHS centre in the UK to offer patients suffering from obstructive sleep apnœa (OSA) a choice of nerve stimulation devices to manage their condition.
-
Concerned about the impact of climate change on people with neurological conditions, Professor Sanjay Sisodiya has established established a consortium of neurological specialists and will be undertaking research.
-
This page has been written for patients having proton beam therapy (PBT) at University College Hospital (UCH).
-
UCLH works in partnership with GPs in Barnet and Enfield to provide a community based ear, nose and throat (ENT) service. The Community ENT service provides specialist advice and treatment for a range of minor ENT conditions.
-
UCLH today marks International Clinical Trials Day, which this year coincides with the National Institute for Health Research (NIHR) campaign encouraging everyone to ‘Be Part of Research.’
File results
-
FOI/2021/0330 - Sexual assault related incidents
-
FOI/2021/0332 - Trust Policy for Information Governance
-
FOI/2021/0333 - Mental health patient complaints
-
FOI/2021/0339 - Defibrotide for the treatment of hepatic veno-occlusive disease
-
FOI/2021/0341 - Total hospital deaths (all causes)
-
FOI/2021/0343 - Hospital admissions and deaths
-
FOI/2021/0345 - Maternity unit closures
-
FOI/2021/0349 - Cancer treatment
-
FOI/2021/0351 - Patients brought to A&E presenting complaint related to mental health
-
FOI/2021/0353 - Operational Pressures Escalation Levels (OPEL) Policy